Domestic firms need to develop combined preparations as new chemical form

Published: 2004-09-09 07:00:00

Updated: 2004-09-09 07:00:00

Pharmaceutical business sources cautioned that Korean companies have to focus on the development of new chemical drugs containing at least two ingredients, as a number of multinational firms are pushing ahead with their R&D projects centered around combined preparations in parallel with steadily ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK